Table 1. In Vivo Antitumor Efficacy at Day 10.
| group | mean TV ± SD | RTV | TGI (%) |
|---|---|---|---|
| control | 2320.48 ± 37.98 | 7.70 ± 0.98 | |
| DOX | 1424.87 ± 64.06 | 5.01 ± 0.67 | 35.02 |
| PET/DOX-DHA | 1031.16 ± 77.37 | 3.45 ± 0.60 | 55.27 |
| group | mean TV ± SD | RTV | TGI (%) |
|---|---|---|---|
| control | 2320.48 ± 37.98 | 7.70 ± 0.98 | |
| DOX | 1424.87 ± 64.06 | 5.01 ± 0.67 | 35.02 |
| PET/DOX-DHA | 1031.16 ± 77.37 | 3.45 ± 0.60 | 55.27 |